GANESHCP vs INDOUS: Stock Comparison
GANESH CONSUMER PRODUCT L is the larger company by market capitalisation. GANESH CONSUMER PRODUCT L shows a higher dividend yield, faster revenue growth and lower leverage, while INDO US BIOTECH shows a lower P/E, a higher ROE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
GANESHCP leads 5; INDOUS leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | GANESHCP | INDOUS |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Packaged Foods | Other Agricultural Products |
Price
| Metric | GANESHCP | INDOUS |
|---|---|---|
| Live Price | ₹187.65 | ₹65.34 |
| Day Change | 0.56% | -1.85% |
| Volume | 1.14 L | 4,878 |
| 52-Week High | ₹295.65 | ₹159 |
| 52-Week Low | ₹144.5 | ₹57.5 |
| Distance from 52W High | -36.53% | -58.91% |
Valuation
| Metric | GANESHCP | INDOUS |
|---|---|---|
| Market Cap | ₹764 Cr | ₹134 Cr |
| P/E Ratio | 14.87x | 0x |
| P/B Ratio | 1.82x | 0x |
| EPS | ₹3.1 | ₹1,69,098.66 |
| Book Value | ₹91.67 | ₹63.54 |
| Dividend Yield | 2.64% | 0% |
Growth
| Metric | GANESHCP | INDOUS |
|---|---|---|
| Revenue Growth (TTM YoY) | -0.9% | -22% |
| EPS Growth (TTM YoY) | 88.1% | -47.3% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | GANESHCP | INDOUS |
|---|---|---|
| ROE | 11.44% | 14.18% |
| ROCE | 16.32% | 10.86% |
| Net Margin | 5.27% | 11.88% |
| Operating Margin | 7.73% | 14.64% |
| Debt to Equity | 0.02x | 0.4x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | GANESHCP | INDOUS |
|---|---|---|
| Promoter Holding | 65.85%▲ 0.2 pp | 68.29% |
| FII Holding | 1.8%▼ 0.46 pp | 0.01% |
| DII Holding | 3.69%▼ 1.81 pp | 0.25%▲ 0.25 pp |
| Public Holding | 28.66%▲ 2.07 pp | 31.45%▼ 0.25 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GANESH CONSUMER PRODUCT L and INDO US BIOTECH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.